Last reviewed · How we verify
[14C]BMS-986177 Solution for Infusion — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
[14C]BMS-986177 Solution for Infusion ([14C]BMS-986177 Solution for Infusion) — Bristol-Myers Squibb.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| [14C]BMS-986177 Solution for Infusion TARGET | [14C]BMS-986177 Solution for Infusion | Bristol-Myers Squibb | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- [14C]BMS-986177 Solution for Infusion CI watch — RSS
- [14C]BMS-986177 Solution for Infusion CI watch — Atom
- [14C]BMS-986177 Solution for Infusion CI watch — JSON
- [14C]BMS-986177 Solution for Infusion alone — RSS
Cite this brief
Drug Landscape (2026). [14C]BMS-986177 Solution for Infusion — Competitive Intelligence Brief. https://druglandscape.com/ci/14c-bms-986177-solution-for-infusion. Accessed 2026-06-09.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing